Survivors of non-small cell lung cancer are at risk for both second primary lung cancers as well as non-lung secondary ...

Clinical predictors of response to immunotherapy in patients with extensive-stage small cell lung cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...

Advances are reshaping treatment for small cell lung cancer, with immunotherapy and emerging options offering hope for longer survival and potential cures. Immunotherapy is changing treatment ...

Frontline: Surgery to remove the tumor is often considered, sometimes followed by chemotherapy or radiation to reduce ...

Despite a significant 48.8% objective response rate and breakthrough therapy status, this regulatory shift reverses years of ...

A 69-year-old Greeley woman had just hiked 8 miles in Sedona, Arizona, when she received a call that she had lung cancer. Despite her active lifestyle, a past of smoking crept up on her without any ...

When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer grows.

A recent study has analyzed the relationship between different air pollutants and the main subtypes of lung cancer.